EMAIL: SFeldman@olshanlaw.com
DIRECT DIAL: 212.451.2234
February 4, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn.: | Tim Buchmiller |
| Office of Life Sciences |
| Re: | OS Therapies Incorporated | |
| Registration Statement on Form S-1 (No. 333-284631) |
Ladies and Gentlemen:
On behalf of OS Therapies Incorporated, a Delaware corporation (the “Company”), we enclose the Company’s request for acceleration of the above-referenced Registration Statement to 4:30 p.m., Eastern time, on Thursday, February 6, 2025, or as soon as practicable thereafter.
Please advise the undersigned of the effectiveness of the Registration Statement.
| Very truly yours, | |
|
/s/ Spencer G. Feldman | |
| Spencer G. Feldman |
| cc: | Paul A. Romness, MPH |